Heparin-induced thrombocytopenia type II because of heparin-coated polytetrafluoroethylene graft used to bypass.
Heparin-induced thrombocytopenia type II is an immune-mediated syndrome that may arise in a time-dependent manner after heparin therapy. Thrombocytopenia and thrombosis in patients exposed to heparin are suggestive of this syndrome.